ea0038p469 | Thyroid | SFEBES2015
Tariq Saher
, Bashari Waiel A
, Barry Katherine
, Ninkovic Mary
, Oyibo Samson O
Introduction: Interferon and Ribavarin-based Hepatitis C therapy can induce or exacerbate autoimmune thyroid dysfunction with variable clinical presentation. Being female, having prior thyroid dysfunction and raised anti-thyroid peroxidase (anti-TPO) antibodies are risk factors. We have a protocol for managing thyroid dysfunction that occurs during hepatitis C antiviral therapy. We present four cases.Case 1: A 48 year old man diagnosed with hepatitis C i...